Skip to main content

Find Clinical Trials

Home
Conditions
Schizophrenia

Clinical trial condition

Schizophrenia

Explore clinical trials studying Schizophrenia. Study availability and eligibility vary by location and protocol.

2,712 public trials 267 recruiting studies

Refine in advanced search Browse all conditions

Schizophrenia trial results

Completed

Safety and Tolerability Study of Lu AF35700 After Repeated Dosing in Patients With Schizophrenia

NCT02202226

Conditions: Mental Disorders, Schizophrenia, Schizophrenia Spectrum and Other Psychotic Disorders
Locations: PAREXEL Phase I Unit Glendale, California, United States

View Trial Details

Completed

Pharmacokinetic Properties of Various Modified Release Tablet Formulations of Lu AF11167

NCT02260830

Conditions: Mental Disorders, Schizophrenia, Schizophrenia Spectrum and Other Psychotic Disorders
Locations: Quotient Clinical Nottingham, United Kingdom

View Trial Details

Completed

Pharmacologic and Clinical Testing of a D1 Agonist for Cognitive Enhancement in Neuropsychiatric Disorders

NCT01519557

Conditions: Mental Disorders, Psychotic Disorders, Schizoaffective Disorder, +2 more
Locations: New York State Psychiatric Institute New York, United States

View Trial Details

Completed

Bioavailability of LY03004 and Risperdal® Consta®

NCT02091388

Conditions: Mental Disorders, Psychotic Disorders, Schizoaffective Disorder, +2 more
Locations: Woodland International Little Rock, Arkansas, United States

Collaborative Neuroscience Network LLC Long Beach, California, United States

Neuropsychiatric Research Center of Orange County Orange, California, United States

Comprehensive Clinical Development Washington D.C., District of Columbia, United States

View Trial Details

Completed

Metacognitive Training in Schizophrenia

NCT01029067

Conditions: Behavior, Behavioral Symptoms, Delusions, +5 more
Locations: University Medical Center Hamburg Eppendorf Hamburg, Free and Hanseatic City of Hamburg, Germany

View Trial Details

Completed

Pharmacokinetic Study of MIN-101 in Healthy Subjects

NCT02232529

Conditions: Mental Disorders, Schizophrenia, Schizophrenia Spectrum and Other Psychotic Disorders
Locations: Quotient Clinical Ruddington, Nottingham, United Kingdom

View Trial Details

Completed

rTMS-induced Cumulative Pattern of sBDNF in Chronic Schizophrenia

NCT01427088

Conditions: Mental Disorders, Schizophrenia, Schizophrenia Spectrum and Other Psychotic Disorders
Locations: Jeonbuk Provincial Maeumsarang Hospital Wanju, Jeollabuk-do, South Korea

View Trial Details

Completed

Safety and Tolerability Study of Lu AF11167 After Repeated Dosing in Patients With Schizophrenia

NCT02202213

Conditions: Mental Disorders, Schizophrenia, Schizophrenia Spectrum and Other Psychotic Disorders
Locations: Parexel International Glendale, California, United States

View Trial Details

Completed

Prevention of Relapse With Injectable Paliperidone Palmitate Versus Oral Antipsychotics

NCT01081769

Conditions: Disease Attributes, Mental Disorders, Pathologic Processes, +4 more
Locations: Vienna, Austria

Bertrix, Belgium

Ghent, Belgium

Liège, Belgium

View all 94 locations

View Trial Details

Completed

Trial of Aripiprazole Intramuscular Depot (OPC-14597, Lu AF41155) in the Acute Treatment of Adults With Schizophrenia

NCT01663532

Conditions: Mental Disorders, Schizophrenia, Schizophrenia Spectrum and Other Psychotic Disorders
Locations: Little Rock, Arkansas, United States

Springdale, Arkansas, United States

Anaheim, California, United States

Carson, California, United States

View all 49 locations

View Trial Details